The FDA posted a summary of observations made from the Agency’s inspection of a Regeneron (REGN) facility in Ireland that was conducted from March 6-10 and 13-14 of 2023 to its website.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REGN: